Literature DB >> 23733190

Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.

Devram Sampat Ghorpade1, Sahana Holla, Akhauri Yash Sinha, Senthil Kumar Alagesan, Kithiganahalli Narayanaswamy Balaji.   

Abstract

Pathogenic mycobacteria employ several immune evasion strategies such as inhibition of class II transactivator (CIITA) and MHC-II expression, to survive and persist in host macrophages. However, precise roles for specific signaling components executing down-regulation of CIITA/MHC-II have not been adequately addressed. Here, we demonstrate that Mycobacterium bovis bacillus Calmette-Guérin (BCG)-mediated TLR2 signaling-induced iNOS/NO expression is obligatory for the suppression of IFN-γ-induced CIITA/MHC-II functions. Significantly, NOTCH/PKC/MAPK-triggered signaling cross-talk was found critical for iNOS/NO production. NO responsive recruitment of a bifunctional transcription factor, KLF4, to the promoter of CIITA during M. bovis BCG infection of macrophages was essential to orchestrate the epigenetic modifications mediated by histone methyltransferase EZH2 or miR-150 and thus calibrate CIITA/MHC-II expression. NO-dependent KLF4 regulated the processing and presentation of ovalbumin by infected macrophages to reactive T cells. Altogether, our study delineates a novel role for iNOS/NO/KLF4 in dictating the mycobacterial capacity to inhibit CIITA/MHC-II-mediated antigen presentation by infected macrophages and thereby elude immune surveillance.

Entities:  

Keywords:  Chromatin Histone Modification; Innate Immunity; Interferon; Macrophages; Major Histocompatibility Complex (MHC); MicroRNA; Mycobacteria; Nitric Oxide; Signal Transduction; Toll-like Receptors (TLR)

Mesh:

Substances:

Year:  2013        PMID: 23733190      PMCID: PMC3711323          DOI: 10.1074/jbc.M113.472183

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  New insights into the function of granulomas in human tuberculosis.

Authors:  Timo Ulrichs; Stefan H E Kaufmann
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

2.  Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK.

Authors:  Nuria Rodriguez; Roland Lang; Nina Wantia; Christine Cirl; Tanja Ertl; Susanne Dürr; Hermann Wagner; Thomas Miethke
Journal:  J Leukoc Biol       Date:  2008-09-17       Impact factor: 4.962

3.  Massive monoclonal expansion of CD4 T-cells specific for a Mycobacterium tuberculosis ESAT-6 peptide.

Authors:  Tobias Hodapp; Urban Sester; Ulrich Mack; Mahavir Singh; Thomas Meier; Elisabeth Wiech; Paul Fisch; Stephan Ehl; Martina Sester
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

Review 4.  Protein kinase C: structure, function, and regulation.

Authors:  A C Newton
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

5.  A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis.

Authors:  Mary Anne Mashruwala; Amanda K Smith; Devin R Lindsey; Margaret Moczygemba; Rick A Wetsel; John R Klein; Jeffrey K Actor; Chinnaswamy Jagannath
Journal:  Tuberculosis (Edinb)       Date:  2011-12-05       Impact factor: 3.131

Review 6.  Advances in tuberculosis vaccine strategies.

Authors:  Yasir A W Skeiky; Jerald C Sadoff
Journal:  Nat Rev Microbiol       Date:  2006-06       Impact factor: 60.633

Review 7.  Krüppel-like factors: three fingers in control.

Authors:  Shivalingappa K Swamynathan
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

8.  Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection.

Authors:  Nicole D Pecora; Scott A Fulton; Scott M Reba; Michael G Drage; Daimon P Simmons; Nancy J Urankar-Nagy; W Henry Boom; Clifford V Harding
Journal:  Cell Immunol       Date:  2008-08-30       Impact factor: 4.868

9.  Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes.

Authors:  Arnar Geirsson; Raymond J Lynch; Indu Paliwal; Alfred L M Bothwell; Graeme L Hammond
Journal:  Biochem Biophys Res Commun       Date:  2003-02-14       Impact factor: 3.575

10.  IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha.

Authors:  Mélanie Giroux; Manuel Schmidt; Albert Descoteaux
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

View more
  16 in total

Review 1.  HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Authors:  Barbara Seliger; Matthias Kloor; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

2.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

3.  Mycobacterium tuberculosis EsxL inhibits MHC-II expression by promoting hypermethylation in class-II transactivator loci in macrophages.

Authors:  Srabasti Sengupta; Saba Naz; Ishani Das; Abdul Ahad; Avinash Padhi; Sumanta Kumar Naik; Geetanjali Ganguli; Kali Prasad Pattanaik; Sunil Kumar Raghav; Vinay Kumar Nandicoori; Avinash Sonawane
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

4.  Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer.

Authors:  Dingxie Liu; Paul Hofman
Journal:  Cell Oncol (Dordr)       Date:  2022-05-11       Impact factor: 7.051

5.  PRMT5 epigenetically regulates the E3 ubiquitin ligase ITCH to influence lipid accumulation during mycobacterial infection.

Authors:  Salik Miskat Borbora; Raju S Rajmani; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS Pathog       Date:  2022-06-03       Impact factor: 7.464

6.  MUSASHI-Mediated Expression of JMJD3, a H3K27me3 Demethylase, Is Involved in Foamy Macrophage Generation during Mycobacterial Infection.

Authors:  Sahana Holla; Praveen Prakhar; Vikas Singh; Anupama Karnam; Tanushree Mukherjee; Kasturi Mahadik; Pankti Parikh; Amit Singh; R S Rajmani; Subbaraya G Ramachandra; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS Pathog       Date:  2016-08-17       Impact factor: 6.823

7.  Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function.

Authors:  Cheryl Hemingway; Maurice Berk; Suzanne T Anderson; Victoria J Wright; Shea Hamilton; Hariklia Eleftherohorinou; Myrsini Kaforou; Greg M Goldgof; Katy Hickman; Beate Kampmann; Johan Schoeman; Brian Eley; David Beatty; Sandra Pienaar; Mark P Nicol; Michael J Griffiths; Simon J Waddell; Sandra M Newton; Lachlan J Coin; David A Relman; Giovanni Montana; Michael Levin
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

8.  Epigenetic reader BRD4 supports mycobacterial pathogenesis by co-modulating host lipophagy and angiogenesis.

Authors:  Tanushree Mukherjee; Bharat Bhatt; Praveen Prakhar; Gaurav Kumar Lohia; R S Rajmani; Kithiganahalli Narayanaswamy Balaji
Journal:  Autophagy       Date:  2021-06-28       Impact factor: 13.391

9.  Epigenetic response in mice mastitis: Role of histone H3 acetylation and microRNA(s) in the regulation of host inflammatory gene expression during Staphylococcus aureus infection.

Authors:  Rahul Modak; Susweta Das Mitra; Madavan Vasudevan; Paramanandhan Krishnamoorthy; Manoj Kumar; Akshay V Bhat; Mani Bhuvana; Sankar K Ghosh; Bibek R Shome; Tapas K Kundu
Journal:  Clin Epigenetics       Date:  2014-06-30       Impact factor: 6.551

10.  MEK inhibition enhances efficacy of bacillus Calmette-Guérin on bladder cancer cells by reducing release of Toll-like receptor 2-activated antimicrobial peptides.

Authors:  Young Mi Whang; Su Bin Jin; Serk In Park; In Ho Chang
Journal:  Oncotarget       Date:  2017-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.